A study has shown that a widely used drug may offer new hope for treating a rare genetic disease known as Pompe disease. Researchers found that the drug enhances the effectiveness of enzyme replacement therapy, leading to improved muscle function in patients. This promising development could change the standard of care for those affected, providing a new avenue for treatment options.
